The 5th Tianjin International Lymphoma Academic Conference, as an academic platform to promote international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and cooperation in the field of international lymphoma. During the conference, "Hematology Frontier" specially invited Professor Owen O’Connor, President of the Lymphoma Alliance and from the University of Virginia Cancer Center, and Professor Zhengzi Qian from the Tianjin Medical University Cancer Hospital to engage in a dialogue between China and the rest of the world, reviewing the current status and latest advances in the treatment of relapsed/refractory peripheral T-cell lymphoma (R/R PTCL).

Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, "Hematology Frontier" specially invited Dr. Norbert Claude Gorin from Hôpital Saint-Antoine in Paris, a member of the French National Academy of Medicine, and a foreign academician of the Chinese Academy of Engineering, to discuss the evolution of the role of autologous transplantation in the treatment of acute myeloid leukemia (AML) and the challenges and potential of immunotherapy in AML treatment.

Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, "Hematology Frontier" specially invited Dr. Salomon Manier from the Hematology Department of Lille University Hospital in France to discuss the current treatment challenges, emerging treatment plans, and management in the elderly and frail patient population for patients with transplant-ineligible newly diagnosed multiple myeloma (TIE-NDMM).